MedPath

Calcipotriene

Calcipotriene Topical Solution, 0.005% (Scalp Solution)

Approved
Approval ID

53c9942a-e861-493f-95c2-53446bc5f06d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 19, 2022

Manufacturers
FDA

Akorn

DUNS: 117696873

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Calcipotriene

PRODUCT DETAILS

NDC Product Code50383-732
Application NumberANDA077579
Marketing CategoryC73584
Route of AdministrationTOPICAL
Effective DateMarch 4, 2022
Generic NameCalcipotriene

INGREDIENTS (7)

ISOPROPYL ALCOHOLInactive
Code: ND2M416302
Classification: IACT
MENTHOL, UNSPECIFIED FORMInactive
Code: L7T10EIP3A
Classification: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671P
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CITRATE, UNSPECIFIED FORMInactive
Code: 1Q73Q2JULR
Classification: IACT
CALCIPOTRIENE HYDRATEActive
Quantity: 0.05 mg in 1 mL
Code: S7499TYY6G
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Calcipotriene - FDA Drug Approval Details